Target intelligence / Profile preview

Retinol metabolism

Molecular classification
Metabolic pathway, Enzyme, Nuclear receptor, Transcription factor, Transport protein
01

Overview

Retinol metabolism is the complex biochemical pathway responsible for the uptake, storage, and conversion of Vitamin A (retinol) into its biologically active metabolites, primarily 11-cis-retinal and all-trans-retinoic acid (ATRA) (StatPearls: Vitamin A, 2023; NIH ODS, 2022). This pathway involves a series of enzymatic reactions mediated by retinol dehydrogenases (RDHs), retinaldehyde dehydrogenases (RALDHs), and lecithin:retinol acyltransferase (LRAT), as well as transport by retinol-binding proteins (RBPs) (Nutrients, 2020). The active metabolite 11-cis-retinal is essential for the visual cycle in the retina, while ATRA serves as a ligand for nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which act as transcription factors to regulate genes involved in cell growth, differentiation, and apoptosis (Chem Rev, 2014). Although Retinol metabolism refers to a biological process rather than a single molecular target, its components are critical in clinical medicine. Pharmacological interventions often utilize synthetic retinoids that mimic these metabolites to treat acne, psoriasis, and acute promyelocytic leukemia, though these therapies are limited by significant safety concerns, most notably severe teratogenicity.

Other names
Vitamin A metabolismRetinoid metabolismRetinoid cycleRetinoid signaling pathway
02

Mechanism of action

Retinoids act as ligands for nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which function as transcription factors to regulate gene expression. Some drugs also inhibit the degradation of retinoic acid or influence the enzymatic conversion of retinol to its active metabolites.

03

Biological functions

VisionCell differentiationImmune responseEmbryonic developmentEpithelial maintenanceApoptosis
04

Disease associations

Vitamin A deficiencyAcne vulgarisPsoriasisAcute promyelocytic leukemiaNight blindnessXerophthalmiaIchthyosisCancer
05

Safety considerations

TeratogenicityHypervitaminosis AHepatotoxicityHypertriglyceridemiaMucocutaneous toxicity
06

Interacting drugs

Tretinoin

7 more in the full profile.

07

Biomarkers

Serum retinolRetinol-binding protein 4 (RBP4)Transthyretin (TTR)

Beyond the preview

Go deeper on Retinol metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinol metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call